Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00171145
Status:
COMPLETED
Last Update Posted:
2008-01-23
First Post:
2005-09-12
Brief Title:
A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder
Sponsor:
Novartis
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Overactive Bladder Syndrome |
Keywords:
| Name | View |
|---|---|
| Overactive Bladder incontinence antimuscarinic warning time darifenacin | View |